Andover, MA, United States of America

Tracy S Mitchell

This inventor holds 16 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Fibronectin Binding Proteins. Top assignees: Bristol-Myers Squibb Compnay, Bristol Meyers Squibb Company. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tracy S Mitchell. Retrieved from https://idiyas.com/inventor/tracy-s-mitchell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 7.7

ph-index = 6

Forward Citations = 189(Granted Patents)


Location History:

  • Billerica, MA (US) (2013 - 2015)
  • Andover, MA (US) (2016 - 2024)

Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Fibronectin
Serum Albumin
PCSK9
Binding Domains
Scaffold Proteins
Fc Fusion Proteins
Type III Domains
Fast-off Rate
Molecular Binding
Linkers
Novel Arrangements
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tracy S. Mitchell

Introduction

Tracy S. Mitchell, a prominent inventor based in Andover, MA, has significantly contributed to the field of biotechnology with a remarkable portfolio of 15 patents. Her inventive spirit and dedication to scientific advancement have yielded innovative solutions in the treatment of cholesterol-related diseases.

Latest Patents

Among her latest patents is the invention of fibronectin-based scaffold domain proteins that bind PCSK9. This groundbreaking work pertains to the use of these innovative proteins in therapeutic applications designed to treat atherosclerosis, hypercholesterolemia, and other cholesterol-related disorders. Additionally, she has developed fast-off rate serum albumin binding fibronectin type III domains, which are polypeptides that include tenth fibronectin type III domains (Fn3) capable of binding to serum albumin. These fusion molecules can be integrated with a heterologous protein, demonstrating potential in various diagnostic and therapeutic applications.

Career Highlights

Tracy has built a distinguished career, working with some of the leading organizations in the pharmaceutical industry, including Bristol-Myers Squibb Company. Her experience in these prominent companies has enriched her expertise in biotechnology and therapeutics, positioning her as a leading innovator in her field.

Collaborations

Throughout her career, Tracy S. Mitchell has collaborated with esteemed colleagues, such as Ray Camphausen and Jonathan Harry Davis. These partnerships have facilitated the exchange of ideas and fostered advancements in their research endeavors, underscoring the importance of teamwork in innovation.

Conclusion

Tracy S. Mitchell's innovative contributions, especially in the realm of fibronectin-based proteins and therapeutics, reflect her commitment to improving human health. As she continues to advance her research and inventions, her work is poised to have a lasting impact on the medical community and beyond. The breadth of her patents exemplifies her role as a pioneering inventor in the biotechnology landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…